Related Experiment Videos

Obesity, hyperlipidemia, and hyperuraecemia in young and old hypertensive patients

Nazir Ahmed1, Waqas Anwar, Huma Waqas

  • 1Department of Medicine, Frontier Medical College, Abbottabad, Pakistan. dr-nazir-ahmed-malik@yahoo.com

Journal of Ayub Medical College, Abbottabad : JAMC
|November 12, 2010
PubMed

Insights

Hypertension, obesity, and high lipid and uric acid levels are linked to cardiovascular disease. This study found increased BMI more common in younger hypertensive patients, but other conditions were not age-associated.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Hypertension, obesity, hyperlipidemia, and hyperuricemia are significant cardiovascular disease risk factors.
  • Understanding the prevalence of these conditions in different age groups of hypertensive patients is crucial for targeted interventions.

Purpose of the Study:

  • To assess and compare the prevalence of obesity, hyperlipidemia, and hyperuricemia in young versus elderly hypertensive patients.
  • To identify age-specific risk factors associated with hypertension.

Main Methods:

  • A cross-sectional study involving 86 hypertensive patients (age ≥ 15 years) was conducted.
  • Patients were categorized into younger (<46 years) and older (≥46 years) groups.
  • Exclusion criteria included endocrine diseases, pregnancy, coarctation of aorta, and renal disease-related hypertension.

Main Results:

  • Overall overweight/obesity was 70.9%, significantly higher in younger patients (86.2%) than older patients (63.2%).
  • Prevalence of hypercholesterolemia (27.9%), hypertriglyceridemia (66.3%), and hyperuricemia (37.2%) showed no significant age-related differences.
  • Mean BMI was higher in the younger group (29.7 ± 5.2) compared to the older group (26.9 ± 4.7).

Conclusions:

  • Hypercholesterolemia, hypertriglyceridemia, and hyperuricemia are not significantly associated with age in hypertensive patients.
  • Elevated Body Mass Index (BMI) is more prevalent in younger individuals with hypertension.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...